表面マーカーの同定と細胞の分類の使用は、リンパ球を超えて、単球、マクロファージ、骨髄幹細胞、腫瘍細胞の同定まで広がっています。ハイブリドーマ技術とフローサイトメトリーを相乗的に組み合わせることで、両方の技術の用途がさらに拡大します。今後 5 年間の細胞表面マーカー分析の主な傾向は、サンプル前処理と分析自体のさらなる簡素化になるでしょう。
この本レポートでは、アメリカ、ヨーロッパ（フランス、ドイツ、イタリア、スペイン、イギリス）、日本におけるCD4、CD8、CD34細胞表面マーカー検査について、臨床的意義や現在の検査室での実施状況、国別・市場セグメント別の5年間の検査量予測など、詳細な概要を紹介しています。
このレポートは、モノクローナル抗体、IT、DNA プローブ、バイオチップ/マイクロアレイ、およびその他のテクノロジーの市場応用の調査、自動分析装置の機能と操作特性のレビュー、革新的な技術や製品を開発している大手サプライヤーと最近の市場参入者の紹介、そして、代替の市場浸透戦略と参入障壁/リスクを特定します。
目次
Table of Contents
I. Introduction
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8
° Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
° Electrical Aperture-Impedance Analyzers
° Light Scatter Analyzers
b. System Review
° Abbott
° Beckman Coulter/Danaher
° Biocode Hycel
° Drew-Scientific
° Horiba
° Menarini
° Nihon Kohden
° Siemens Healthineers
° Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
° Becton Dickinson
° Beckman Coulter/Danaher
E. Current Market Needs and Future Demand For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. France : Forecasts by Test and Market Segment
IV. Germany : Forecasts by Test and Market Segment
V. Italy : Forecasts by Test and Market Segment
VI. Japan : Forecasts by Test and Market Segment
VII. Spain : Forecasts by Test and Market Segment
VIII. U.K. : Forecasts by Test and Market Segment
IX. U.S. : Forecasts by Test and Market Segment
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
XIII. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications
List of Tables
France, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
France, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Germany, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Italy, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Japan, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Hospital Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
Spain, Ambulatory Care Center Estimated
Cell Surface Marker Test Volume
U.K., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.K., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Hospital Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated
Cell Surface Marker Test Volume
